Display Settings:

Format

Send to:

Choose Destination
    Dev Biol. 2008 Dec 1;324(1):139-50. Epub 2008 Sep 25.

    DNA methyltransferase 1o functions during preimplantation development to preclude a profound level of epigenetic variation.

    Source

    Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

    Abstract

    Most mouse embryos developing in the absence of the oocyte-derived DNA methyltransferase 1o (DNMT1o-deficient embryos) have significant delays in development and a wide range of anatomical abnormalities. To understand the timing and molecular basis of such variation, we studied pre- and post-implantation DNA methylation as a gauge of epigenetic variation among these embryos. DNMT1o-deficient embryos showed extensive differences in the levels of methylation in differentially methylated domains (DMDs) of imprinted genes at the 8-cell stage. Because of independent assortment of the methylated and unmethylated chromatids created by the loss of DNMT1o, the deficient embryos were found to be mosaics of cells with different, but stable epigenotypes (DNA methylation patterns). Our results suggest that loss of DNMT1o in just one cell cycle is responsible for the extensive variation in the epigenotypes in both embryos and their associated extraembryonic tissues. Thus, the maternal-effect DNMT1o protein is uniquely poised during development to normally ensure uniform parental methylation patterns at DMDs.

    PMID:
    18845137
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2645800
    Free PMC Article

    Images from this publication.See all images (7) Free text

    Fig. 4
    Fig. 7
    Fig. 5
    Fig. 6
    Fig. 1
    Fig. 2
    Fig. 3

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk